A study to assess Drug‐drug Interactions of Single Therapeutic Oral Doses of Atogepant and Sumatriptan in Healthy adults
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Atogepant (Primary) ; Sumatriptan
- Indications Migraine
- Focus Pharmacokinetics
- 02 Oct 2020 According to an AbbVie media release, data from this trial will be presented as posters at the 2020 Virtual Migraine Trust International Symposium.
- 15 Jul 2020 New trial record
- 20 Jun 2020 Results presented at the 62nd Annual Scientific Meeting of the American Headache Society